Weighing the consequences: body mass index trajectories after pediatric venous thromboembolism

Weighing the consequences: body mass index trajectories after pediatric venous thromboembolism

Saved in:

Bibliographic Details
Main Author:	Julie Jaffray
Format:	Article
Language:	English
Published:	Elsevier 2025-05-01
Series:	Research and Practice in Thrombosis and Haemostasis
Online Access:	http://www.sciencedirect.com/science/article/pii/S2475037925002158
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Weighing the evidence on GLP1s and venous thromboembolism
by: Damon E. Houghton, et al.
Published: (2025-05-01)

Evaluation of the impact of body mass index on venous thromboembolism risk factors.
by: Fatemeh Tajik, et al.
Published: (2020-01-01)

The balancing act after pediatric venous thromboembolism
by: Hilary Whitworth, et al.
Published: (2025-08-01)

Changes in body mass index following venous thromboembolism in children: a prospective cohort study
by: Mary P. Dang, et al.
Published: (2025-03-01)

Associations Between Body Mass Index, Body Image Satisfaction, and Self‐Weighing During a Behavioral Weight Loss Program
by: Armaan Shetty, et al.
Published: (2025-06-01)

Descriptive Epidemiology of Venous Thromboembolism in Pediatric Orthopedic Patients
by: Hillary Brenda Nguyen, BA, et al.
Published: (2025-03-01)

Modelling future trajectories of obesity and body mass index in England.
by: Linda J Cobiac, et al.
Published: (2021-01-01)

Venous thromboembolic complications
by: G. G. Khubulava, et al.
Published: (2019-02-01)

Osteoporosis and venous thromboembolism
by: Irina Aleksandrovna Baranova, et al.
Published: (2011-02-01)

Preeclampsia and venous thromboembolism
by: K. N. Grigoreva, et al.
Published: (2022-07-01)

Results of prophylaxis of venous thromboembolism after orthopedic operations
by: B. S. Sukovatykh, et al.
Published: (2017-10-01)

Cost-Consequence Analysis of Apixaban Versus Rivaroxaban for Managing Patients with Venous Thromboembolism in Saudi Arabia
by: Abdulaali R. Almutairi PhD, et al.
Published: (2025-02-01)

Impact of the Body Mass on Complications and Outcome in Multiple Trauma Patients: What Does the Weight Weigh?
by: Hagen Andruszkow, et al.
Published: (2013-01-01)

Pediatric venous thromboembolism: incidence and patient profile in a single Brazilian institution
by: Liana Ariel de Siqueira Lira, et al.
Published: (2024-11-01)

Racial disparities in extended venous thromboembolism prophylaxis after hysterectomy.
by: Wenbo Wu, et al.
Published: (2025-01-01)

Body Mass Index, Age and Gender Have No Impact on Venous Thromboembolism Rates; An Epidemiologic Study of 1434 Foot and Ankle Surgeries Performed at a Single Academic Medical Center
by: Jared M. May BS, et al.
Published: (2024-12-01)

Clinical overview of venous thromboembolism
by: Gustav Schellack, et al.
Published: (2016-01-01)

Venous thromboembolism in surgical practice.
by: I. L. Verkholaz, et al.
Published: (2018-12-01)

HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
by: Michele Bibas, et al.
Published: (2011-07-01)

Males and Body Image: "Weighing In" on a Growing Concern
by: Eboni Baugh
Published: (2007-08-01)

Males and Body Image: "Weighing In" on a Growing Concern
by: Eboni Baugh
Published: (2007-08-01)

Reduced proliferation of endothelial colony-forming cells in unprovoked venous thromboembolic disease as a consequence of endothelial dysfunction.
by: Rubicel Hernandez-Lopez, et al.
Published: (2017-01-01)

Venous thromboembolism swine model with reflux-induced venous hypertension
by: Mengjun Wang, MD, et al.
Published: (2024-01-01)

Venous Thromboembolism Risk Assessment Audit
by: Sunday Neru, et al.
Published: (2025-06-01)

SICKLE CELL DISEASE AND VENOUS THROMBOEMBOLISM
by: Zohreh Rahimi, et al.
Published: (2011-05-01)

SICKLE CELL DISEASE AND VENOUS THROMBOEMBOLISM
by: Zohreh Rahimi, et al.
Published: (2011-01-01)

Venous thromboembolism in patients with heart failure
by: O. V. Averkov, et al.
Published: (2011-08-01)

Rheumatoid arthritis and venous thromboembolic events
by: M. A. Satybaldyeva
Published: (2016-10-01)

PHARMACOECONOMIC ASPECTS OF THE PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS AFTER LARGE JOINTS REPLACEMENT
by: A. V. Rudakova
Published: (2015-09-01)

Tendency to overeat predicts an elevated body mass index trajectory across school-age years
by: Catharina Sarkkola, et al.
Published: (2025-02-01)

Editorial: Inflammation and immune factors in venous thromboembolism
by: Steven P. Grover, et al.
Published: (2025-05-01)

New horizons in the pharmacological management of venous thromboembolism
by: Andreas Verstraete, et al.
Published: (2025-06-01)

Systemic hormonal contraception and risk of venous thromboembolism
by: Oskari Heikinheimo, et al.
Published: (2022-08-01)

Pharmacological prophylaxis of venous thromboembolism in surgical patients
by: С.І. Саволюк, et al.
Published: (2024-12-01)

Venous thromboembolism in two adolescents with Down syndrome
by: Tsunehiko Kurokami, et al.
Published: (2018-08-01)

Venous thromboembolism in abdominoplasty: a prevention protocol
by: Thatiana Ambrogini Justino, et al.
Published: (2018-03-01)

Hyperhomocysteinemia prevalence among patients with venous thromboembolism
by: R. Ben Salah, et al.
Published: (2024-12-01)

Intercontinental variations in the presentation and management of venous thromboembolism
by: Cassius Iyad Ochoa Chaar, MD, MS, et al.
Published: (2025-01-01)

Comment on: Multimorbidity, comorbidity, frailty, and venous thromboembolism
by: Maria I. Zervou, et al.
Published: (2025-02-01)

Detection of venous thromboembolism by proteomic serum biomarkers.
by: Santhi K Ganesh, et al.
Published: (2007-06-01)